Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2025
  • Volume: 18
  • Issue: 4

Elevated Levels of Mannose-Binding Lectin (MBL) in patients with Type 2 Diabetes and its Potential Association with Nephropathy and Retinopathy

  • Author:
  • Islam Hamad1,**, Amani A. Harb2, Eman Y. Abu-Rish3, Shereen M. Aleidi3, Ola Sallam3, Haneen El-Huneidi4, Bashar Alkhalidi3, Mohammad Mohammad5, Mohammad H. Semreen6,7, Eman Abu-Gharbieh6,8,3, Yasser Bustanji6,8,3,*
  • Total Page Count: 8
  • Page Number: 1579 to 1586

1Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Amman, Jordan

2Department of Basic Sciences, Faculty of Arts and Sciences, Al-Ahliyya Amman University, Amman, Jordan

3School of Pharmacy, The University of Jordan, Amman, 11942, Jordan

4Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

5SANA Pharma Company, Amman, Jordan

6Sharjah Institute for Medical Research, University of Sharjah, Sharjah, P.O. Box 27272, United Arab Emirates

7College of Pharmacy, University of Sharjah, Sharjah, P.O. Box 27272, United Arab Emirates

8College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates

*Corresponding Author E-mail: ybustanji@sharjah.ac.ae

**i.hamad@aum.edu.jo

Online Published on 24 July, 2025.

Abstract

The hepatic protein Mannose-binding lectin (MBL) serves a pivotal role in the acute-phase immune response, potentially influencing the pathogenesis of type 2 diabetes (T2DM) and its associated complications, such as nephropathy and retinopathy. Recent evidence suggests that elevated plasma MBL levels may serve as a predictive marker for albuminuria in T2DM patients. Moreover, it is postulated that MBL ligands are present within the kidneys of diabetic individuals, thereby facilitating the deposition of MBL within the renal parenchyma or other target organs, thereby exacerbating pathological processes. This study aimed to assess serum MBL levels in T2DM patients and explore potential associations between MBL levels and the onset of diabetic complications. A cross-sectional investigation was conducted, encompassing 92 participants, comprising 71 individuals diagnosed with T2DM and 21 age- and sex-matched healthy counterparts. Among the T2DM cohort, patients were stratified into nephropathic and non-nephropathic subgroups based on the presence of nephropathy, as well as into subgroups with or without retinopathy based on retinopathy status. Serum MBL levels were quantified utilizing Enzyme-Linked Immunosorbent Assay (ELISA). The mean MBL levels were found to be significantly elevated in diabetic patients compared to healthy controls (1736 vs. 730.99 ng/mL, p-value = 0.011). Furthermore, MBL levels exhibited a statistically significant increase in individuals with microalbuminuria compared to normoalbuminuric T2DM patients (p-value = 0.019). Notably, a significant association was observed between heightened MBL levels in diabetic patients and the occurrence of retinopathy . The findings of this study support the hypothesis implicating MBL in the pathogenesis of T2DM and the initiation and progression of its associated complications, including nephropathy and retinopathy. Nevertheless, further investigation is warranted to delineate the precise underlying mechanisms governing the relationship between MBL and T2DM pathophysiology.

Keywords

Diabetes, MBL, Mannose-Binding Lectin, Microalbumin, Nephropathy, Retinopathy